COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,639 Articles (22,913 medRxiv, 8,726 bioRxiv)

Most recent first Previous |  Page 1368: Articles 13671-13680  | Next

COVID-19 Mortality in Women and Men in Sub-Saharan Africa: A Cross Sectional Study
Dalal, J., Triulzi, I., James, A., Nguimbis, B., Dri, G. G., Venkatasubramanian, A., Lucie, N. T. R., Mesa, S. B., Somerville, C., Turchetti, G., Stoll, B., Abbate, J. L., Mboussou, F., Impouma, B., Keiser, O., Coelho, F. C.
10.1101/2021.07.31.21261422 — Posted: 2021-08-02
Performance of three molecular tests for SARS-CoV-2 on a university campus estimated jointly with Bayesian latent class modeling
Perkins, A., Stephens, M., Alvarez Barrios, W., Cavany, S. M., Rulli, L., Pfrender, M. E.
10.1101/2021.07.31.21261425 — Posted: 2021-08-02
COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020 - April, 2021
Barchuk, A., Skougarevskiy, D., Kouprianov, A., Shirokov, D., Dudkina, O., Tursun-zade, R., Sergeeva, M., Tychkova, V., Komissarov, A., Zheltukhina, A., Lioznov, D., Isaev, A., Pomerantseva, E., Zhikrivetskaya, S., Sofronova, Y., Blagodatskikh, K., Titaev, K., Barabanova, L., Danilenko, D.
10.1101/2021.07.31.21261428 — Posted: 2021-08-02
Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
Du, S., Liu, P., Zhang, Z., Xiao, T., Yasimayi, A., Huang, W., Wang, Y., Cao, Y. R., Xie, X. S., Xiao, J.
10.1101/2021.07.30.454402 — Posted: 2021-08-01
Evolutionary dynamics of indels in SARS-CoV-2 spike glycoprotein
Rao, R. S. P., Ahsan, N., Xu, C., Su, L., Verburgt, J., Fornelli, L., Kihara, D., Xu, D.
10.1101/2021.07.30.454557 — Posted: 2021-08-01
Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152
Yadav, P. D., Sahay, R. R., Sapkal, G., Nyayanit, D., Shete, A., Deshpande, G., Patil, D., Gupta, N., Kumar, S., Abraham, P., Panda, S., Bhargava, B.
10.1101/2021.07.30.454511 — Posted: 2021-08-01
Multi-layered transcriptomic analyses reveal an immunological overlap between COVID-19 and hemophagocytic lymphohistiocytosis associated with disease severity
Schimke, L. F., Marques, A. H., Baiocchi, G. C., Prado, C. A., Fonseca, D. L., Freire, P. P., Placa, D. R., Filgueira, I. S., Salgado, R. C., Jansen-Marques, G., Oliveira, A. E., Peron, J. P. S., Barbuto, J. A. M., Camara, N. O. S., Calich, V. L., Ochs, H. D., Condino-Neto, A., Overmyer, K. A., Coon, J. J., Balnis, J., Jaitovich, A., Schulte-Schrepping, J., Ulas, T., Schultze, J. L., Nakaya, H. I., Jurisica, I., Marques, O. C.
10.1101/2021.07.30.454529 — Posted: 2021-08-01
Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2
Brady, M., Combs, A., Venkatraman, C., Solorzano, A., Johnson, A., McQuaid, C., Rahman, A., Leyva, H., Kwok, W.-C. E., Wood, R. W., Deane, R.
10.1101/2021.07.30.454520 — Posted: 2021-08-01
Specialized interferon ligand action in COVID19
Galbraith, M. D., Kinning, K. T., Sullivan, K. D., Araya, P., Smith, K. P., Granrath, R. E., Shaw, J. R., Baxter, R., Jordan, K. R., Russell, S., Dzieciatkowska, M., Reisz, J. A., Ghosh, T., Monte, A., Benett, T. D., Hansen, K., Hsieh, E. W., D'Alessandro, A., Espinosa, J. M.
10.1101/2021.07.29.21261325 — Posted: 2021-08-01
COVID-19 vaccine response in people with multiple sclerosis
Tallantyre, E. C., Vickaryous, N., Anderson, V., Asardag, A. N., Baker, D., Bestwick, J. P., Bramhall, K., Chance, R., Evangelou, N., George, K., Giovannoni, G., Grant, L., Harding, K. E., Hibbert, A., Ingram, G., Jones, M., Kang, A. S., Loveless, S., Moat, S., Robertson, N. P., Schmierer, K., Shah, S. N., Simmons, J., Upcott, M., Willis, M. D., Jolles, S., Dobson, R.
10.1101/2021.07.31.21261326 — Posted: 2021-08-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).